dexmedetomidine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DEXMEDETOMIDINE MYLAN dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial
AUST R: 271410
Active ingredients:
dexmedetomidine hydrochloride

Dosage form:
Injection, concentrated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800 274 276

From
16 Jun 2022
to
30 Nov 2022

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in consumer demand

Management action:
Other brands are available.

PRECEDEX READY TO USE dexmedetomidine hydrochloride 200 micrograms/50 mL injection for intravenous infusion bottle
AUST R: 234023
Active ingredients:
dexmedetomidine hydrochloride

Dosage form:
Injection, intravenous infusion

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
12 Aug 2022
to
20 Sep 2022

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand

DEXMEDETOMIDINE-TEVA dexmedetomidine (as HCl) 200 micrograms/2mL concentrated injection vial
AUST R: 290530
Active ingredients:
dexmedetomidine hydrochloride

Dosage form:
Injection, concentrated

Sponsor:
Teva Pharma Australia Pty Ltd

Phone:
1800 288 382

Deletion from market:
28 Mar 2022

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability